SR 90107A/Org 31540, a Novel Anti‐Factor Xa Antithrombotic Agent
Open Access
- 1 March 1997
- journal article
- Published by Wiley in Cardiovascular Drug Reviews
- Vol. 15 (1), 1-26
- https://doi.org/10.1111/j.1527-3466.1997.tb00321.x
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Synthetic Analogues of the Antithrombin III– Binding Pentasaccharide Sequence of HeparinArteriosclerosis, Thrombosis, and Vascular Biology, 1995
- Plasma TFPI activity after intravenous injection of pentasaccharide (PS) and unfractionated heparin in rabbitsThrombosis Research, 1994
- The Unique Antithrombin III Binding Domain of Heparin: A Lead to New Synthetic AntithromboticsAngewandte Chemie International Edition in English, 1993
- Inhibition of factor X and factor V activation by dermatan sulfate and a pentasaccharide with high affinity for antithrombin III in human plasmaEuropean Journal of Biochemistry, 1990
- Free factor Xa is on the main pathway of thrombin generation in clotting plasmaBiochimica et Biophysica Acta (BBA) - General Subjects, 1989
- In Vitro Studies of the Interaction of Heparin, Low Molecular Weight Heparin and Heparinoids with PlateletsAnnals of the New York Academy of Sciences, 1989
- STRUCTURAL STUDIES ON A BIOLOGICALLY ACTIVE HEXASACCHARIDE OBTAINED FROM HEPARINAnnals of the New York Academy of Sciences, 1981
- Anticoagulant properties of heparin fractionated by affinity chromatography on matrix-bound antithrombin III and by gel filtrationThrombosis Research, 1976
- Anticoagulant activity of heparin: Separation of high‐activity and low‐activity heparin species by affinity chromatography on immobilized antithrombinFEBS Letters, 1976
- The separation of active and inactive forms of heparinBiochemical and Biophysical Research Communications, 1976